PSA Screening Declines, Especially Among Men Most Likely to Benefit
May 18th 2015When the United States Preventive Services Task Force (USPSTF) recommended against routine PSA screening for early detection of prostate cancer in May 2012, it caused a sea change in practice patterns among primary care physicians.
Study Points to Possible Role for Statins in Lung Cancer
May 13th 2015Statin use before or after a diagnosis of lung cancer may be linked to a reduced risk of death from the disease, according to findings of a recent study which found that patients who used statins in the year before a lung cancer diagnosis had a statistically significant 12% reduction in lung cancer-specific deaths.
E-cigarette Users Nearly 60% Less Likely To Quit Than Traditional Cigarette Smokers
May 11th 2015E-cigarettes, championed by some as a smoking-cessation tool, may actually decrease the likelihood of quitting smoking, according to a recent population-based study of 1000 smokers published in The American Journal of Public Health.
What Is Lynch Syndrome and Why Is It Important?
April 28th 2015Lynch syndrome (LS) is a hereditary syndrome that causes a marked increased risk of colorectal and other cancers. It is inherited in an autosomal dominant pattern, which means that it is due to a mutation in one copy of a gene (in LS, a DNA mismatch repair gene).
Understanding Why Black Women Have Denser Breasts May Help Target Those With Highest Cancer Risk
April 21st 2015Breast density, which is associated with breast cancer risk, is higher in black/African-American women than in white women, according to research presented at the AACR Annual Meeting.
HPV Vaccine Effective in Women With Prior Exposure to the Virus
April 21st 2015Newly reported findings from a randomized phase III vaccine efficacy trial demonstrate that HPV vaccination may offer protection against HPV-related cancers across multiple tumor sites in women aged 18-25 who had been previously exposed to the human papillomavirus, with the vaccine effective in more than half of these women.
Early Trial of Anti-PD-L1 Agent Shows Promise in TNBC
April 21st 2015The PD-L1 inhibitor MPDL3280A demonstrated a 19% objective response rate (ORR) with 75% of responses ongoing in pretreated patients with metastatic triple-negative breast cancer (TNBC), according to findings from an ongoing phase I study presented at the 2015 AACR Annual Meeting.
More Evidence of Aspirin's Benefits in Reducing Colorectal Cancer Risk
April 20th 2015A recent study joins a body of evidence suggesting that long-term, regular aspirin use is associated with a reduced risk for cancer, with the most dramatic reduction being seen in colorectal cancer incidence.
Nighttime Fasting May Help Reduce Breast Cancer Risk
April 20th 2015New research reported at the AACR Annual Meeting has found that decreasing the number of hours spent eating each day and increasing the number of hours spent fasting overnight may reduce a woman's risk of developing breast cancer.